Team:ETH Zurich/Wetlab/Genome Reduction

Genome reduction

Goal

In this section we discuss about how to randomly delete chromosomal fragments of E. coli in order to reduce the physical amount of genomic DNA.

Method

To reach our goal of random deletion of chromosomal fragments, we want to synthesize a frequently cutting restriction enzyme along with the simultaneous, shortly delayed, or even continuous synthesis of a ligase. The restriction enzyme will cut genomic DNA in a random fashion in vivo, while the ligase performs its job of religation. Assuming that the genomic DNA is cut at several sites within one cell, religation will lead to the exclusion of chromosomal fragments in some cells. Multiple rounds of restriction and religation will therefore lead to a markedly reduced genome.

Proof of concept

In 1997 Ren et al. showed that in vivo religation of linearized vector and insert is possible by overexpression of the T4 ligase (1). Our idea, however, relies on the assumption that in vivo restriction and religation is possible and leads to the exclusion of chromosomal DNA. We are trying to verify these assumptions in several experiments which will from now on be refered to as our “proof of concept”.

Our proof of concept relies the following construct (not shown are ribosomal binding sites behind both SceI restriction sites and a terminator following the RFP):

construct for proof of concept

The above construct was ordered at GeneArt and is supposed to be integrated into the genome of a wild-type E. coli strain (MG1655). We are planning to use the lambda red recombination system established by Wanner and Datsenko (2) to integrate our construct into the tryptophanase A gene resulting in the knockout of the latter.

Additionally, we ordered DNA encoding the T4 ligase and the SceI restriction enzyme. Transformation of these plasmid-encoded enzymes into cells carrying the proof of concept construct is supposed to yield bacteria that can be induced to express T4 and SceI.

Before synthesis of T4 and SceI, cells carrying the proof of concept construct do not synthesize RFP. After synthesis of the restriction enzyme, SceI will cut the bacterial chromosome at the sites indicated above. The ligase will then religate the construct, leading to the exclusion of the sensitivity gene and the terminator in some of the cells. Hence, these cells would synthesize the RFP reporter protein and could easily be identified:

proof of concept

Additionally, adding sucrose to the medium would kill all cells that have not eliminated the sacB sensitivity gene. Hence, only RFP-synthesizing bacteria would survive, which would presumably facilitate detection.

Modification of proof of concept

Unfortunately, up to now we have not received our construct for the proof of concept. Therefore, we are working on a modified construct:

modified construct for proof of concept

For this purpose, a commonly used RFP reporter plasmid is used. SceI restriction sites are introduced by cutting the plasmid in front of and after the RFP gene and ligating oligonucleotide duplexes containing the desired restriction sites.

After transformation of bacteria with the construct shown above and plasmids containing the genes coding for SceI restriction enzyme and the T4 ligase, induction of gene expression will lead to in vivo cutting and religation of the RFP-encoding plasmid, leading to the loss of the RFP gene from the plasmid. Therefore, if cells lose the RFP signal after induction of the restriction enzyme and ligase, we have proven that in vivo restriction and ligation is possible and can lead to the exclusion of DNA fragments:

modified proof of concept

SceI restriction enzyme

SceI is a site-specific homing endonuclease. It is extremely rare-cutting as it recognizes an 18 bp sequence. These properties make SceI a perfect restriction enzyme for our proof of concept for which the restriction enzyme should only cut the sites of our constructs indicated above. However, for our goal of minimizing E. coli’s genome we will need to use a frequently cutting restriction enzyme which will potentially lead to severe damage of the cell’s genome. In order to limit this damage, we want to be able to pulse the expression of the restriction enzyme. Therefore, we are cloning an inducible promoter in front of SceI.

T4 ligase

T4 is the commonly used ligase for in vitro cloning. For in vivo cloning, high levels of T4 are advantageous not only for improving the efficiency of religation leading to the exclusion of chromosomal fragments, but also for limiting DNA damage. However, constitutive overexpression of T4 might lead to immediate religation without the exclusion of chromosomal fragments. Therefore, we are cloning T4 behind an IPTG-inducible promoter (R0010), and, as alternative approach, behind several constitutive promoter of differing strengths. Another idea would be to clone both SceI and T4 behind the same promoter, so that induction would lead to simultaneous expression of both enzymes.

Lab results

Goals

For the proof of concept we want to clone following constructs:

Picture with 2 plasmids; plasmid 1: RFP construct with SceI-site, Resistenzgen1. plasmid 2: T4 and SceI, Resistenzgen 2

These two plasmids are going to be transduced into the same host. The RFP generator enclosed from two SceI-restriction sites will be on a low-copy plasmid, like pCK01, to reduce the number of cutting targets for SceI. Whereas T4 ligase and SceI restriction enzyme will be placed on a high-copy plasmid. Expression of T4 and SceI will be induced in order to cut out the whole RFP generator and religate the digested plasmid in vivo. This will be easily detected by the disappearance of red fluorescence of the cells. We have chosen to use RFP, since they are easily distinguishable on plates from the ones which dont express RFP anymore. By using antibiotica it will be easily assured that only colonies will survive which contain the plasmids with the two resistence genes.

Modified proof of concept

For the RFP generator we used the Biobrick BBa_J04450 and cloned SceI-restriction sites into its EcoRI- and PstI-site.

picture showing BBaJ04450, indicating of E and P-site where oligos with SceI-site are inserted.

For the SceI-restriction sites we ordered oligos containing the SceI-recognition site and at its ends the overhangs for EcoRI- and PstI-site respectively. The oligos were hybridised and cloned into BBa_J04450. Successful cloning were verified by digestion and gel electrophoresis.

Oligos for SceI-site integrated at EcoRI-site:

       EcoR_SceI_up 
       AATTCAGTTACGCTAGGGATAACAGGGTAATATAGC 
 
       EcoR_SceI_down 
       AATTGCTATATTACCCTGTTATCCCTAGCGTAACTG

Oligos for SceI-site integrated at PstI-site:

       Pst_site_up
       AGTTACGCTAGGGATAACAGGGTAATATAGCTGCA

       Pst_site_down
       GCTATATTACCCTGTTATCCCTAGCGTAACTTGCA

Hybridised Oligos:

picture with hybridised oligos showing overhangs, killed site, and SceI-recognition site

SceI restriction enzyme and T4 ligase

We performed following clonings to bring SceI and T4 under the control of different promoters by standard Biobrick assembly:

• SceI under the lac-Promoter: [http://partsregistry.org/Part:BBa_K142205 BBa_K142205]

• T4 under the lac-Promoter: [http://partsregistry.org/Part:BBa_K142204 BBa_K142204]

• T4 under a medium constitutive promoter: [http://partsregistry.org/Part:BBa_K142207 BBa_K142207]

• T4 under a strong constitutive promoter: [http://partsregistry.org/Part:BBa_K142206 BBa_K142206]

References

(1) [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T39-3V4BTWM-CH&_user=791130&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_version=1&_urlVersion=0&_userid=791130&md5=5f7b6177feaf9c0d06cd0e9b334a43ce Ren Z. J., Baumann R. G., Black L. W. (1997): Cloning of linear DNAs in vivo by overexpressed T4 DNA ligase: construction of a T4 phage hoc gene display vector. Gene 22 195(2):303-11.]

(2) [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10829079 Datsenko K. A., Wanner B. L. (2000): One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci 97 (12):6640-5.]